Tim Meagher address these questions and more in a new GLP 1 FAQ, informed by Munich Res Life Science Report 2025 and the latest clinical research
Start Now About Semaglutide Originally developed as a treatment for diabetes, semaglutide stands out as the first medication since Saxenda's approval in 2014 specifically designated to address chronic weight management in the 70% of American adults classified as overweight or obese
By activating stem cells, X39 helps the body repair faster, recover more efficiently, and feel more youthful
Top Tips for Success This electrolyte drink is so easy to customize
In clinical trials, retatrutide is administered as a once-weekly subcutaneous injection
GLP-1s are no longer only useful for weight loss and diabetesthey are critical for building metabolic resilience and reducing inflammation, making them a powerful component of whole-person, lasting health